SCHEMBL3674440

SCHEMBL3674440

CCOc1cccc(C(C)C(=O)O)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 2/20 0.70
AKR1C2 P52895 2/20 0.70
PTGS1 P23219 4/20 0.67
PTGS2 P35354 6/20 0.66
ALDH1A1 P00352 3/20 0.54
SMN1; SMN2 Q16637 3/20 0.51
MAPT P10636 2/20 0.51
CXCR1 P25024 2/20 0.51
CXCR2 P25025 2/20 0.51
KDM4E B2RXH2 2/20 0.51
LMNA P02545 2/20 0.51
MAPK1 P28482 2/20 0.51
RECQL P46063 1/20 0.51
CYP3A4 P08684 1/20 0.51
HPGD P15428 1/20 0.51
PMP22 Q01453 1/20 0.51
SLC22A6 Q4U2R8 1/20 0.51
HSD17B10 Q99714 1/20 0.51
CXCL8 P10145 1/20 0.51
THPO P40225 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3673447 0.88 PTGS1 (0.63) AKR1C3AKR1C2PTGS1PTGS2ALDH1A1
SCHEMBL4681615 0.86 AKR1C3 (0.52) AKR1C3AKR1C2PTGS1PTGS2ALDH1A1
SCHEMBL4681610 0.86 AKR1C3 (0.52) AKR1C3AKR1C2PTGS1PTGS2ALDH1A1
SCHEMBL6288738 0.86 PTGS1 (0.65) AKR1C3AKR1C2PTGS1PTGS2ALDH1A1
SCHEMBL28133951 0.86 PTGS1 (0.65) AKR1C3AKR1C2PTGS1PTGS2ALDH1A1
SCHEMBL11003663 0.85 ALDH1A1 (0.56) AKR1C3AKR1C2PTGS1PTGS2ALDH1A1
SCHEMBL4740646 0.84 PTGS1 (0.63) AKR1C3AKR1C2PTGS1PTGS2ALDH1A1
Hydrochloric Acid SCHEMBL10920754 0.84 ALDH1A1 (0.55) AKR1C3AKR1C2PTGS1PTGS2ALDH1A1
SCHEMBL6401266 0.84 ALDH1A1 (0.51) AKR1C3AKR1C2PTGS1PTGS2ALDH1A1
SCHEMBL6401263 0.84 ALDH1A1 (0.51) AKR1C3AKR1C2PTGS1PTGS2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7812038-B2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors ENCYSIVE PHARMACEUTICALS, INC. (US) 2010-10-12 US disclosed
US-20060276476-A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors BIEDIGER RONALD J 2006-12-07 US disclosed
US-6972296-B2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors ENCYSIVE PHARMACEUTICALS INC. (US) 2005-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276476-A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors VCAM1, ICAM1, ITGA1 AKR1C3 809/4885AKR1C2 844/4885PTGS1 1253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.